ZA995345B - Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus. - Google Patents

Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus.

Info

Publication number
ZA995345B
ZA995345B ZA9905345A ZA995345A ZA995345B ZA 995345 B ZA995345 B ZA 995345B ZA 9905345 A ZA9905345 A ZA 9905345A ZA 995345 A ZA995345 A ZA 995345A ZA 995345 B ZA995345 B ZA 995345B
Authority
ZA
South Africa
Prior art keywords
lentivirus
compositions
methods
immunodeficiency virus
associated disease
Prior art date
Application number
ZA9905345A
Other languages
English (en)
Inventor
Ruitang Deng
Michael George Sheppard
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA995345B publication Critical patent/ZA995345B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15061—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9905345A 1998-08-24 1999-08-23 Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus. ZA995345B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9764598P 1998-08-24 1998-08-24

Publications (1)

Publication Number Publication Date
ZA995345B true ZA995345B (en) 2001-02-23

Family

ID=22264449

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9905345A ZA995345B (en) 1998-08-24 1999-08-23 Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus.

Country Status (13)

Country Link
EP (1) EP0997529B1 (xx)
JP (2) JP2000116386A (xx)
CN (1) CN1253176A (xx)
AR (1) AR020340A1 (xx)
AT (1) ATE313629T1 (xx)
AU (1) AU773647B2 (xx)
BR (1) BR9903877A (xx)
CA (1) CA2280582A1 (xx)
DE (1) DE69929024T2 (xx)
ES (1) ES2252918T3 (xx)
NZ (1) NZ337389A (xx)
TW (1) TWI237664B (xx)
ZA (1) ZA995345B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074625A3 (en) 1999-06-14 2002-01-02 Pfizer Products Inc. DNA vaccine against feline immunodeficiency virus
JP2004511251A (ja) * 2000-10-17 2004-04-15 インパス，　インコーポレイテッド 核酸増幅コントロール
US7345152B2 (en) * 2002-09-12 2008-03-18 Wyeth Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency-encoded glycoprotein
GB0603749D0 (en) * 2006-02-24 2006-04-05 Moving Sun Ltd Immune system stimulant and process of manufacturing the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04126085A (ja) * 1990-05-11 1992-04-27 Tonen Corp ネコ免疫不全ウイルスの遺伝子ｒｎａに相補性を示すｄｎａ
US5736378A (en) * 1991-09-12 1998-04-07 The Scripps Research Institute Molecular cloning and characterization of the feline immunodeficiency virus isolate PPR
WO1997032983A1 (en) * 1996-03-05 1997-09-12 The Regents Of The University Of California Recombinant live feline immunodeficiency virus and proviral dna vaccines
US6331616B1 (en) * 1997-03-05 2001-12-18 North Carolina State University Nucleic acids obtained from the envelope coding region of feline immunodeficiency virus molecular clone designated JSY3
GB9704977D0 (en) * 1997-03-11 1997-04-30 Univ Glasgow FIV vaccine
EP1045921A2 (en) * 1998-01-16 2000-10-25 Chiron Corporation Feline immunodeficiency virus gene therapy vectors
EP1074625A3 (en) * 1999-06-14 2002-01-02 Pfizer Products Inc. DNA vaccine against feline immunodeficiency virus

Also Published As

Publication number Publication date
EP0997529A3 (en) 2002-05-22
DE69929024D1 (de) 2006-01-26
TWI237664B (en) 2005-08-11
JP2004208695A (ja) 2004-07-29
AR020340A1 (es) 2002-05-08
CA2280582A1 (en) 2000-02-24
AU4456399A (en) 2000-03-09
JP2000116386A (ja) 2000-04-25
AU773647B2 (en) 2004-05-27
BR9903877A (pt) 2001-01-09
ATE313629T1 (de) 2006-01-15
ES2252918T3 (es) 2006-05-16
CN1253176A (zh) 2000-05-17
DE69929024T2 (de) 2006-06-22
EP0997529A2 (en) 2000-05-03
NZ337389A (en) 2001-02-23
EP0997529B1 (en) 2005-12-21

Similar Documents

Publication Publication Date Title
EP1128832A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS AND RELATED DISEASES
PL345196A1 (en) Agents for combating plant pests
GB2337755B (en) Virus vaccine
ZA200004956B (en) Vaccine composition.
ZA993938B (en) Ziprasidone formulations.
AU1621799A (en) Fungicidal compositions and methods, and compounds and methods for the preparation thereof
IT248598Y1 (it) Scudo per la protezione dorsale.
HUP0102483A3 (en) Pharmaceutical compositions containing androst-5-ene-3betha,17betha-diol
ZA200005510B (en) Pharmaceutical composition.
ZA9710272B (en) Pharmaceutical compositions comprising diaryl-cyclomethylenpyrazole compounds.
DE69935903D1 (de) Genmutierte tiere
ZA200106734B (en) Fungicide compositions for protecting fruits.
HK1022853A1 (en) Pharmaceutical compositions.
AU2001259987A1 (en) Process for recovering bone and oil from animal byproducts
ZA992440B (en) Poison bait compositions.
ZA995345B (en) Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus.
ZA991232B (en) New compound and pharmaceutical compositions thereof.
ZA995239B (en) Pesticidal compositions.
HK1044117A1 (en) Pharmaceutical composition.
ZA200005697B (en) Paroxetine compositions.
ZA200006557B (en) Agents for combating plant pests.
GB9807287D0 (en) Biocidal compositions
GB2367230B (en) Baffle arrangement for animal feeder or the like
GB0023202D0 (en) An animal trap
ZA956791B (en) Substituted triazolinones as crop protection agents.